Erik Andreas Rye Berg, Stefano Fiorentini, Jørgen Avdal, Bjørnar Grenne, Knut Haakon Stensæth, Peter Thomas While, Torvald Espeland, Rune Wiseth, Hans Torp, Svend Aakhus
{"title":"经胸三维高脉冲重复频率多普勒超声心动图定量评价瓣膜反流。","authors":"Erik Andreas Rye Berg, Stefano Fiorentini, Jørgen Avdal, Bjørnar Grenne, Knut Haakon Stensæth, Peter Thomas While, Torvald Espeland, Rune Wiseth, Hans Torp, Svend Aakhus","doi":"10.1093/ehjimp/qyae138","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>To improve quantification of valvular regurgitation, a 3D high-pulse repetition frequency Doppler (3D HPRFD) method was developed for regurgitant volume (RVol) estimation from transthoracic echocardiography (TTE). Although successfully applied <i>in vitro</i> and in selected clinical cases, a systematic clinical validation of 3D HPRFD has not been published. Hence, our aims were to investigate (i) feasibility of 3D HPRFD and (ii) correlation between 3D HPRFD and RVol estimates obtained by the 2D proximal isovelocity surface area (PISA) method and cardiac magnetic resonance (CMR) in patients with either aortic regurgitation (AR) or mitral regurgitation (MR).</p><p><strong>Methods and results: </strong>We included 45 patients with AR (42% mild, 40% moderate, and 18% severe) and 45 with MR (67% mild, 24% moderate, and 9% severe). Median time between start of TTE and start of CMR was 1.5 h, minimizing changes in load. Overall feasibility of 3D HPRFD was 56% in AR and 44% in MR. Feasibility was only 25% in patients with severe regurgitation. In AR, estimated RVol from 3D HPRF did not correlate with estimated RVol from PISA or CMR [Spearman <i>rho</i> = 0.06 (<i>P</i> = 0.78) and 0.04 (<i>P</i> = 0.4), respectively]. In MR, RVol estimates from 3D HPRFD correlated with PISA (<i>rho</i> = 0.72, <i>P</i> < 0.001) but not with CMR (<i>rho</i> = 0.31, <i>P</i> = 0.43).</p><p><strong>Conclusion: </strong>Regurgitant volume estimation by 3D HPRFD had a low feasibility, especially in severe regurgitation, and in general correlated poorly with PISA and CMR estimates. In its current state, 3D HPRFD is not ready for clinical use.</p>","PeriodicalId":94317,"journal":{"name":"European heart journal. Imaging methods and practice","volume":"2 3","pages":"qyae138"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11694712/pdf/","citationCount":"0","resultStr":"{\"title\":\"Quantification of valvular regurgitation by transthoracic 3D high pulse repetition frequency Doppler echocardiography.\",\"authors\":\"Erik Andreas Rye Berg, Stefano Fiorentini, Jørgen Avdal, Bjørnar Grenne, Knut Haakon Stensæth, Peter Thomas While, Torvald Espeland, Rune Wiseth, Hans Torp, Svend Aakhus\",\"doi\":\"10.1093/ehjimp/qyae138\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aims: </strong>To improve quantification of valvular regurgitation, a 3D high-pulse repetition frequency Doppler (3D HPRFD) method was developed for regurgitant volume (RVol) estimation from transthoracic echocardiography (TTE). Although successfully applied <i>in vitro</i> and in selected clinical cases, a systematic clinical validation of 3D HPRFD has not been published. Hence, our aims were to investigate (i) feasibility of 3D HPRFD and (ii) correlation between 3D HPRFD and RVol estimates obtained by the 2D proximal isovelocity surface area (PISA) method and cardiac magnetic resonance (CMR) in patients with either aortic regurgitation (AR) or mitral regurgitation (MR).</p><p><strong>Methods and results: </strong>We included 45 patients with AR (42% mild, 40% moderate, and 18% severe) and 45 with MR (67% mild, 24% moderate, and 9% severe). Median time between start of TTE and start of CMR was 1.5 h, minimizing changes in load. Overall feasibility of 3D HPRFD was 56% in AR and 44% in MR. Feasibility was only 25% in patients with severe regurgitation. In AR, estimated RVol from 3D HPRF did not correlate with estimated RVol from PISA or CMR [Spearman <i>rho</i> = 0.06 (<i>P</i> = 0.78) and 0.04 (<i>P</i> = 0.4), respectively]. In MR, RVol estimates from 3D HPRFD correlated with PISA (<i>rho</i> = 0.72, <i>P</i> < 0.001) but not with CMR (<i>rho</i> = 0.31, <i>P</i> = 0.43).</p><p><strong>Conclusion: </strong>Regurgitant volume estimation by 3D HPRFD had a low feasibility, especially in severe regurgitation, and in general correlated poorly with PISA and CMR estimates. In its current state, 3D HPRFD is not ready for clinical use.</p>\",\"PeriodicalId\":94317,\"journal\":{\"name\":\"European heart journal. Imaging methods and practice\",\"volume\":\"2 3\",\"pages\":\"qyae138\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-12-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11694712/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European heart journal. Imaging methods and practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/ehjimp/qyae138\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/7/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European heart journal. Imaging methods and practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/ehjimp/qyae138","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
目的:为了提高瓣膜性反流的量化,建立了一种三维高脉冲重复频率多普勒(3D HPRFD)方法,用于经胸超声心动图(TTE)估计反流容积(RVol)。尽管3D HPRFD在体外和选定的临床病例中成功应用,但尚未发表系统的临床验证。因此,我们的目的是研究(i) 3D HPRFD的可行性和(ii) 3D HPRFD与主动脉瓣反流(AR)或二尖瓣反流(MR)患者通过2D近端等速表面积(PISA)方法和心脏磁共振(CMR)获得的RVol估计之间的相关性。方法和结果:我们纳入了45例AR患者(42%为轻度,40%为中度,18%为重度)和45例MR患者(67%为轻度,24%为中度,9%为重度)。从TTE开始到CMR开始的中位时间为1.5小时,负荷变化最小。3D HPRFD的总体可行性在AR中为56%,在mr中为44%,在严重反流患者中仅为25%。在AR中,3D HPRF估计的RVol与PISA或CMR估计的RVol不相关[Spearman rho分别= 0.06 (P = 0.78)和0.04 (P = 0.4)]。在MR中,3D HPRFD的RVol估计值与PISA相关(rho = 0.72, P < 0.001),但与CMR无关(rho = 0.31, P = 0.43)。结论:3D HPRFD估计反流体积的可行性较低,特别是在严重反流时,通常与PISA和CMR估计相关性较差。在目前的状态下,3D HPRFD还不能用于临床。
Quantification of valvular regurgitation by transthoracic 3D high pulse repetition frequency Doppler echocardiography.
Aims: To improve quantification of valvular regurgitation, a 3D high-pulse repetition frequency Doppler (3D HPRFD) method was developed for regurgitant volume (RVol) estimation from transthoracic echocardiography (TTE). Although successfully applied in vitro and in selected clinical cases, a systematic clinical validation of 3D HPRFD has not been published. Hence, our aims were to investigate (i) feasibility of 3D HPRFD and (ii) correlation between 3D HPRFD and RVol estimates obtained by the 2D proximal isovelocity surface area (PISA) method and cardiac magnetic resonance (CMR) in patients with either aortic regurgitation (AR) or mitral regurgitation (MR).
Methods and results: We included 45 patients with AR (42% mild, 40% moderate, and 18% severe) and 45 with MR (67% mild, 24% moderate, and 9% severe). Median time between start of TTE and start of CMR was 1.5 h, minimizing changes in load. Overall feasibility of 3D HPRFD was 56% in AR and 44% in MR. Feasibility was only 25% in patients with severe regurgitation. In AR, estimated RVol from 3D HPRF did not correlate with estimated RVol from PISA or CMR [Spearman rho = 0.06 (P = 0.78) and 0.04 (P = 0.4), respectively]. In MR, RVol estimates from 3D HPRFD correlated with PISA (rho = 0.72, P < 0.001) but not with CMR (rho = 0.31, P = 0.43).
Conclusion: Regurgitant volume estimation by 3D HPRFD had a low feasibility, especially in severe regurgitation, and in general correlated poorly with PISA and CMR estimates. In its current state, 3D HPRFD is not ready for clinical use.